VANCOUVER, British Columbia, Feb. 17, 2021 (GLOBE NEWSWIRE) — New Leaf Ventures Inc. (CSE: NLV) (OTC: NLVVF) (“New Leaf,” “NLV” or the “Company”), a management and investment organization dedicated to evaluating, investing and accelerating advanced stage operations in the North American Cannabis sector advises that its New Leaf USA venture is pleased to announce the launch of a new nation-wide CBD-only product line under its highly popular premier Dama Brand.
The Company’s flagship Dama Brand product team today announced extensive plans for entry into the growing CBD marketplace. The proposed lineup will feature herbal blend tinctures, soft gels, and topicals. These proposed high-quality hemp products will benefit from a nation-wide rollout launching in Q1 2021. The new products will be marketed direct to consumer through an e-commerce platform and concurrently wholesaled to multi-outlet grocery, and pharmacy retailers.
With growing global consumer interest in the CBD market, particular emphasis on source-origin and attention to high grade cultivation and premium nutrient inputs are paramount to meet the criteria of well-informed health-conscious individuals. NLV brings decades of extensive cannabis industry knowledge to understand and choose the best formulations. The team’s passion for the healing properties of the hemp plant brings great pride and excitement to supply consumers not only in Washington but across the entire United States.
“The CBD market is evolving and expanding, and we see an opportunity to lead the sector through the direct application of our industry knowledge and experience” said Dax Colwell, CEO, New Leaf USA & Director of New Leaf Ventures Inc. “We can educate consumers about the benefits of different cannabinoids and holistic plant science with a trusted, safe, effective product.”
In November of last year, New Leaf announced the development of a CBD beverage, and this latest project will round out and extend the overall product offering to retailers and consumers alike. The Company’s commitment to CBD extends co-founder Dax Colwell’s personal vision. He has been a champion of CBD since he launched ‘Leaf of Hope’ in November 2013 for 30 families that provided “at risk” children with a CBD-rich strain of cannabis known as AC/DC. Children in the program ranged in age from 3-20, most of whom are suffering from intractable epilepsy diagnoses. The results from the program were incredibly positive, seeing a reduction in seizure frequency in addition to tremendous quality of life improvements.
CBD is a non-psychoactive cannabinoid, native to Cannabis. Hemp products are classified through the FDA as containing less than .3% THC. Mounting scientific evidence is supporting the anecdotal efficacy of CBD regarding a host of disorders. Products will include plant based herbal formulations designed for wellness, balance, reduction of stress, and body tension.
According to a recent report by Research and Markets “Global CBD Oil Market 2021-2025”, the market is poised to grow by $3.05 billion during 2021-2025 progressing at a CAGR of 27% during the forecast period.
About New Leaf Ventures Inc. (CSE: NLV) (OTC: NLVVF)
New Leaf Ventures Inc. is developing a cannabis sector-based scalable securities concept of focused financing and applied management to achieve earnings growth through targeted investment. The Company’s flagship enterprise is New Leaf USA and its subsidiaries, which provide licenses, consulting services, real property, intellectual property and equipment for lease and ancillary services to a Washington-based Tier 3 Producer/Processor focused on cultivating, growing, processing, packaging, and distributing cannabis and cannabis related products. Find out more at: https://newleafventuresinc.com/.
For further information, please contact:
New Leaf Ventures Inc.
Invictus Investor Relations
Tel: +1 (604) 330-9220
Forward Looking Statement
This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; ability to realize benefits from its recent corporate appointments; ability to retain its key personnel; the intention to grow the Company’s business and operations; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information is based on the assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; and the Company’s ability to secure financing on reasonable terms.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks as described in the Company’s management discussion and analysis for year ended December 31, 2019 under the heading “Risks and Uncertainties”. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.